References
- Alkjaersig N, Fletcher A, Joist H, Chaplin H, Jr. Hemostatic alterations accompanying sickle cell pain crises. J Lab Clin Med 1976; 88: 440–449
- Hebbel R P, Eaton J W, Steinberg M H, White J G. Erythrocyte/endothelial interactions in the pathogenesis of sickle cell disease: A real logical assessment. Blood Cells 1982; 8: 163–173
- Mohandas N, Evans E, Kukan B. Adherence of sickle erythrocytes to vascular endothelial cells: Requirement for both cell membrane changes and plasma factors. Blood 1984; 64: 282–287
- Wautier J L, Galacteros F, Wautier M P, et al. Clinical manifestations and erythrocyte adhesion of endothelium in sickle cell syndrome. Am J Hematol 1985; 19: 121–130
- Stuart M, Sills R H. Deficiency of plasma prostacyclin or PGI2 regenerating ability in sickle cell anemia. Br J Haematol 1981; 48: 545–550
- Buchanan G R, Holtkamp C A. Plasma levels of platelet and vascular prostaglandin derivatives in children with sickle cell anaemia. Thromb Haemost 1985; 54: 394–396
- Metha P, Albiol L. Prostacyclin and platelet aggregation in sickle cell disease. Pediatrics 1982; 70: 354–356
- Metha P. Platelet and vessel wall prostaglandins in patients with sickle cell disease. Eur Paediatr Haematol Oncol 1985; 2: 61–64
- Longeneker G L, Mankad V. Decreased prostacyclin levels in sickle cell disease. Pediatrics 1983; 71: 860–861
- Jaffee B M, Behrman H R, Parker C W. Radioimmunoassay measurement of prostaglandins E, A and F, in human plasma. J Clin Invest 1973; 52: 398–405